Literature DB >> 23727207

Use of stress testing and diagnostic catheterization after coronary stenting: association of site-level patterns with patient characteristics and outcomes in 247,052 Medicare beneficiaries.

Bimal R Shah1, Lisa A McCoy, Jerome J Federspiel, Daniel Mudrick, Patricia A Cowper, Frederick A Masoudi, Barbara L Lytle, Cynthia L Green, Pamela S Douglas.   

Abstract

OBJECTIVES: The aim of this study was to determine diagnostic testing patterns after percutaneous coronary intervention (PCI).
BACKGROUND: Little is known about patterns of diagnostic testing after PCI in the United States or the relationship of these patterns to clinical outcomes.
METHODS: Centers for Medicare and Medicaid Services inpatient and outpatient claims were linked to National Cardiovascular Data Registry CathPCI Registry data from 2005 to 2007. Hospital quartiles of the cumulative incidence of diagnostic testing use within 12 and 24 months after PCI were compared for patient characteristics, repeat revascularization, acute myocardial infarction, and death.
RESULTS: A total of 247,052 patients underwent PCI at 656 institutions. Patient and site characteristics were similar across quartiles of testing use. There was a 9% and 20% higher adjusted risk for repeat revascularization in quartiles 3 and 4 (highest testing rate), respectively, compared with quartile 1 (lowest testing rate) (p = 0.020 and p < 0.0001, respectively). The adjusted risk for death or acute myocardial infarction did not differ among quartiles.
CONCLUSIONS: Although patient characteristics were largely independent of rates of post-PCI testing, higher testing rates were not associated with lower risk for myocardial infarction or death, but repeat revascularization was significantly higher at these sites. Additional studies should examine whether increased testing is a marker for improved quality of post-PCI care or simply increased health care utilization.
Copyright © 2013 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMI; CABG; CMS; Centers for Medicare and Medicaid Services; DES; PCI; acute myocardial infarction; coronary artery bypass grafting; diagnostic catheterization; drug-eluting stent(s); patient outcomes; percutaneous coronary intervention; site-level patterns; stress testing

Mesh:

Year:  2013        PMID: 23727207      PMCID: PMC3962793          DOI: 10.1016/j.jacc.2013.02.093

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  18 in total

1.  Variation in the use of echocardiography.

Authors:  F L Lucas; D E Wennberg; D J Malenka
Journal:  Eff Clin Pract       Date:  1999 Mar-Apr

2.  Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.

Authors:  Kathleen Stergiopoulos; David L Brown
Journal:  Arch Intern Med       Date:  2012-02-27

3.  Temporal trends in the utilization of diagnostic testing and treatments for cardiovascular disease in the United States, 1993-2001.

Authors:  F L Lucas; Michael A DeLorenzo; Andrea E Siewers; David E Wennberg
Journal:  Circulation       Date:  2006-01-24       Impact factor: 29.690

4.  Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. Randomized Intervention Treatment of Angina.

Authors:  S J Pocock; R A Henderson; T Clayton; G H Lyman; D A Chamberlain
Journal:  J Am Coll Cardiol       Date:  2000-03-15       Impact factor: 24.094

5.  The impact of diagnostic testing on therapeutic interventions.

Authors:  D Verrilli; H G Welch
Journal:  JAMA       Date:  1996-04-17       Impact factor: 56.272

6.  The association between local diagnostic testing intensity and invasive cardiac procedures.

Authors:  D E Wennberg; M A Kellett; J D Dickens; D J Malenka; L M Keilson; R B Keller
Journal:  JAMA       Date:  1996-04-17       Impact factor: 56.272

7.  Optimal medical therapy with or without PCI for stable coronary disease.

Authors:  William E Boden; Robert A O'Rourke; Koon K Teo; Pamela M Hartigan; David J Maron; William J Kostuk; Merril Knudtson; Marcin Dada; Paul Casperson; Crystal L Harris; Bernard R Chaitman; Leslee Shaw; Gilbert Gosselin; Shah Nawaz; Lawrence M Title; Gerald Gau; Alvin S Blaustein; David C Booth; Eric R Bates; John A Spertus; Daniel S Berman; G B John Mancini; William S Weintraub
Journal:  N Engl J Med       Date:  2007-03-26       Impact factor: 91.245

8.  A comparison of quality of life scores in patients with angina pectoris after angioplasty compared with after medical therapy. Outcomes of a randomized clinical trial. Veterans Affairs Study of Angioplasty Compared to Medical Therapy Investigators.

Authors:  W E Strauss; T Fortin; P Hartigan; E D Folland; A F Parisi
Journal:  Circulation       Date:  1995-10-01       Impact factor: 29.690

9.  Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.

Authors:  L Pilote; R M Califf; S Sapp; D P Miller; D B Mark; W D Weaver; J M Gore; P W Armstrong; E M Ohman; E J Topol
Journal:  N Engl J Med       Date:  1995-08-31       Impact factor: 91.245

10.  Variation in the use of cardiac procedures after acute myocardial infarction.

Authors:  E Guadagnoli; P J Hauptman; J Z Ayanian; C L Pashos; B J McNeil; P D Cleary
Journal:  N Engl J Med       Date:  1995-08-31       Impact factor: 91.245

View more
  6 in total

1.  Electrocardiograms in Low-Risk Patients Undergoing an Annual Health Examination.

Authors:  R Sacha Bhatia; Zachary Bouck; Noah M Ivers; Graham Mecredy; Jasjit Singh; Ciara Pendrith; Dennis T Ko; Danielle Martin; Harindra C Wijeysundera; Jack V Tu; Lynn Wilson; Kimberly Wintemute; Paul Dorian; Joshua Tepper; Peter C Austin; Richard H Glazier; Wendy Levinson
Journal:  JAMA Intern Med       Date:  2017-09-01       Impact factor: 21.873

2.  Patient Symptoms and Stress Testing After Elective Percutaneous Coronary Intervention in the Veterans Affairs Health Care System.

Authors:  Vinay Kini; Monica Parks; Wenhui Liu; Stephen W Waldo; P Michael Ho; Steven M Bradley; Paul L Hess
Journal:  JAMA Netw Open       Date:  2022-06-01

Review 3.  Validity of inducible ischaemia as a surrogate for adverse outcomes in stable coronary artery disease.

Authors:  Adam Timmis; Antony Raharja; R Andrew Archbold; Anthony Mathur
Journal:  Heart       Date:  2018-06-06       Impact factor: 5.994

4.  Utilization and Costs of Noninvasive Cardiac Tests After Acute Coronary Syndromes: Insights From the Alberta COAPT Study.

Authors:  Kevin R Bainey; Daniel Durham; Yinggan Zheng; Cynthia M Westerhout; Padma Kaul; Robert C Welsh
Journal:  CJC Open       Date:  2019-02-19

5.  UK perspective on the changing landscape of non-invasive cardiac testing.

Authors:  Alex Asher; Rahul Ghelani; George Thornton; Krishnaraj Rathod; Daniel Jones; Andrew Wragg; Adam Timmis
Journal:  Open Heart       Date:  2019-12-05

6.  Use of Cardiac Noninvasive Testing After Emergency Department Discharge: Association of Hospital Network Testing Intensity and Outcomes in Ontario, Canada.

Authors:  Idan Roifman; Lu Han; Maria Koh; Harindra C Wijeysundera; Peter C Austin; Pamela S Douglas; Dennis T Ko
Journal:  J Am Heart Assoc       Date:  2020-10-22       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.